IMMUNIZATION WITH VIRUS-LIKE PARTICLES INDUCES LONG-TERM PROTECTION OF RABBITS AGAINST CHALLENGE WITH COTTONTAIL RABBIT PAPILLOMAVIRUS

Citation
Nd. Christensen et al., IMMUNIZATION WITH VIRUS-LIKE PARTICLES INDUCES LONG-TERM PROTECTION OF RABBITS AGAINST CHALLENGE WITH COTTONTAIL RABBIT PAPILLOMAVIRUS, Journal of virology, 70(2), 1996, pp. 960-965
Citations number
28
Categorie Soggetti
Virology
Journal title
ISSN journal
0022538X
Volume
70
Issue
2
Year of publication
1996
Pages
960 - 965
Database
ISI
SICI code
0022-538X(1996)70:2<960:IWVPIL>2.0.ZU;2-K
Abstract
Rabbits were immunized with recombinant baculovirus-produced virus-lik e particles (VLPs) of cottontail rabbit papillomavirus (CRPV) to deter mine whether these antigens could induce long-term protection against experimental challenge with CRPV, Infectious CRPV and human papillomav irus type 11 LI VLPs were used as positive and negative control immuno gens, respectively, Three groups of immunized animals were challenged with 10-fold serial dilutions of infectious CRPV at 2 weeks, 6 months, and 12 months after immunizations, Antibody titers in serum reached 1 :10,000 immediately after the final booster immunization and then deca yed to 1:150 at 6 months and 1:100 at 12 months in unchallenged rabbit s, Serum neutralization titers followed similar kinetics, Papillomas g rew on control-immunized rabbits at sites challenged with 10(-1) (100% of sites), 10(-2) (96% of sites), 10(-3) (63% of sites), and 10(-4) ( 13% of sites) dilutions of virus, At 2 weeks after CRPV L1 VLP immuniz ations, the rabbits were completely protected against virus challenge. At both 6 and 12 months after CRPV L1 VLP immunizations, strong prote ction was also observed, In the last two groups, three of seven rabbit s were completely protected and only 1 of 14 or 29% of sites challenge d with 10(-1) dilution of virus grew papillomas, Papillomas growing at these four sites were also reduced in size (3.5 +/- 0.7 mm) at 50 day s postchallenge compared with sites challenged with 10(-1) dilution on control-immunized rabbits (13.2 +/- 4.2 mm), The results demonstrate that strong and long-lasting protection against experimental challenge with papillomaviruses can be achieved with VLP immunogens.